1
|
Forrester R, Dutech G, Akin A, Fassbender ME, Mastren T. An electrochemical generator for the continual supply of 213Bi from 225Ac for use in targeted alpha therapy applications. Nucl Med Biol 2024; 136-137:108941. [PMID: 39002499 DOI: 10.1016/j.nucmedbio.2024.108941] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2024] [Revised: 06/25/2024] [Accepted: 07/08/2024] [Indexed: 07/15/2024]
Abstract
Bismuth-213 is a radionuclide of interest for targeted alpha therapy and is supplied via a radiochemical generator system through the decay of 225Ac. Radionuclide generators employ longer lived "parent" radionuclides to routinely supply shorter-lived "daughter" radionuclides. The traditional 225Ac/213Bi radiochemical generator relies on an organic cation exchange resin where 225Ac binds to the resin and 213Bi is routinely eluted. These resins degrade when they absorb large doses of ionizing radiation (>1 × 106 Gy/mg), which has been observed when the loading activity of 225Ac exceeds 2.59*109 Bq (70 mCi). Herein we report the development of an electrochemical generator for the supply of 213Bi that has the potential to overcome this limitation. Bismuth-213 spontaneously electrodeposits onto nickel foils in 0.1 M hydrochloric acid at 70 °C. Using this method, we were able to plate an average of 73 ± 4 % of the 213Bi in solution and obtain a final 213Bi recovery of 65 ± 8 % in 0.1 M citrate pH 4.5 via reverse electrolysis using titanium as the cathode. The recovered 213Bi had an average radiochemical purity of >99.8 % and was successfully used to radiolabel DOTATATE with an average radiochemical yield of 85.1 % (not optimized).
Collapse
Affiliation(s)
- Ryan Forrester
- Nuclear Engineering Program, University of Utah, 110 Central Campus Dr, Salt Lake City, UT 84112, USA
| | - Guy Dutech
- Chemistry Division, Los Alamos National Laboratory, PO Box 1663, Los Alamos, NM 87545, USA
| | - Andrew Akin
- Chemistry Division, Los Alamos National Laboratory, PO Box 1663, Los Alamos, NM 87545, USA
| | - Michael E Fassbender
- Chemistry Division, Los Alamos National Laboratory, PO Box 1663, Los Alamos, NM 87545, USA
| | - Tara Mastren
- Nuclear Engineering Program, University of Utah, 110 Central Campus Dr, Salt Lake City, UT 84112, USA.
| |
Collapse
|
2
|
Shinada M, Suzuki H, Hanyu M, Igarashi C, Matsumoto H, Takahashi M, Hihara F, Tachibana T, Sogawa C, Zhang MR, Higashi T, Sato H, Kurihara H, Yoshii Y, Doi Y. Trace Metal Impurities Effects on the Formation of [ 64Cu]Cu-diacetyl-bis( N4-methylthiosemicarbazone) ([ 64Cu]Cu-ATSM). Pharmaceuticals (Basel) 2023; 17:10. [PMID: 38275997 PMCID: PMC10821298 DOI: 10.3390/ph17010010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2023] [Revised: 12/15/2023] [Accepted: 12/19/2023] [Indexed: 01/27/2024] Open
Abstract
[64Cu]Cu-diacetyl-bis(N4-methylthiosemicarbazone) ([64Cu]Cu-ATSM) is a radioactive hypoxia-targeting therapeutic agent being investigated in clinical trials for malignant brain tumors. For the quality management of [64Cu]Cu-ATSM, understanding trace metal impurities' effects on the chelate formation of 64Cu and ATSM is important. In this study, we conducted coordination chemistry studies on metal-ATSM complexes. First, the effects of nonradioactive metal ions (Cu2+, Ni2+, Zn2+, and Fe2+) on the formation of [64Cu]Cu-ATSM were evaluated. When the amount of Cu2+ or Ni2+ added was 1.2 mol or 288 mol, equivalent to ATSM, the labeling yield of [64Cu]Cu-ATSM fell below 90%. Little effect was observed even when excess amounts of Zn2+ or Fe2+ were added to the ATSM. Second, these metals were reacted with ATSM, and chelate formation was measured using ultraviolet-visible (UV-Vis) absorption spectra. UV-Vis spectra showed a rapid formation of Cu2+ and the ATSM complex upon mixing. The rate of chelate formation by Ni2+ and ATSM was lower than that by Cu-ATSM. Zn2+ and Fe2+ showed much slower reactions with the ATSM than Ni2+. Trace amounts of Ni2+, Zn2+, and Fe2+ showed little effect on [64Cu]Cu-ATSM' quality, while the concentration of impurity Cu2+ must be controlled. These results can provide process management tools for radiopharmaceuticals.
Collapse
Affiliation(s)
- Mitsuhiro Shinada
- Faculty of Science, Toho University, Funabashi 274-8510, Japan; (M.T.); (T.T.); (Y.D.)
- Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan; (H.S.); (M.H.); (C.I.); (H.M.); (F.H.); (C.S.); (M.-R.Z.); (T.H.)
- Kanagawa Cancer Center, Kanagawa 241-8515, Japan; (H.S.); (H.K.)
| | - Hisashi Suzuki
- Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan; (H.S.); (M.H.); (C.I.); (H.M.); (F.H.); (C.S.); (M.-R.Z.); (T.H.)
| | - Masayuki Hanyu
- Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan; (H.S.); (M.H.); (C.I.); (H.M.); (F.H.); (C.S.); (M.-R.Z.); (T.H.)
| | - Chika Igarashi
- Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan; (H.S.); (M.H.); (C.I.); (H.M.); (F.H.); (C.S.); (M.-R.Z.); (T.H.)
- Kanagawa Cancer Center, Kanagawa 241-8515, Japan; (H.S.); (H.K.)
| | - Hiroki Matsumoto
- Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan; (H.S.); (M.H.); (C.I.); (H.M.); (F.H.); (C.S.); (M.-R.Z.); (T.H.)
- Kanagawa Cancer Center, Kanagawa 241-8515, Japan; (H.S.); (H.K.)
| | - Masashi Takahashi
- Faculty of Science, Toho University, Funabashi 274-8510, Japan; (M.T.); (T.T.); (Y.D.)
- Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan; (H.S.); (M.H.); (C.I.); (H.M.); (F.H.); (C.S.); (M.-R.Z.); (T.H.)
| | - Fukiko Hihara
- Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan; (H.S.); (M.H.); (C.I.); (H.M.); (F.H.); (C.S.); (M.-R.Z.); (T.H.)
| | - Tomoko Tachibana
- Faculty of Science, Toho University, Funabashi 274-8510, Japan; (M.T.); (T.T.); (Y.D.)
- Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan; (H.S.); (M.H.); (C.I.); (H.M.); (F.H.); (C.S.); (M.-R.Z.); (T.H.)
| | - Chizuru Sogawa
- Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan; (H.S.); (M.H.); (C.I.); (H.M.); (F.H.); (C.S.); (M.-R.Z.); (T.H.)
| | - Ming-Rong Zhang
- Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan; (H.S.); (M.H.); (C.I.); (H.M.); (F.H.); (C.S.); (M.-R.Z.); (T.H.)
| | - Tatsuya Higashi
- Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan; (H.S.); (M.H.); (C.I.); (H.M.); (F.H.); (C.S.); (M.-R.Z.); (T.H.)
| | - Hidemitsu Sato
- Kanagawa Cancer Center, Kanagawa 241-8515, Japan; (H.S.); (H.K.)
| | - Hiroaki Kurihara
- Kanagawa Cancer Center, Kanagawa 241-8515, Japan; (H.S.); (H.K.)
| | - Yukie Yoshii
- Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan; (H.S.); (M.H.); (C.I.); (H.M.); (F.H.); (C.S.); (M.-R.Z.); (T.H.)
- Kanagawa Cancer Center, Kanagawa 241-8515, Japan; (H.S.); (H.K.)
| | - Yoshihiro Doi
- Faculty of Science, Toho University, Funabashi 274-8510, Japan; (M.T.); (T.T.); (Y.D.)
| |
Collapse
|
3
|
Cingoranelli SJ, Bartels JL, Kankanamalage PHA, Loveless CS, Rotsch DA, Lapi SE. Production and purification of 43Sc and 47Sc from enriched [ 46Ti]TiO 2 and [ 50Ti]TiO 2 targets. Sci Rep 2023; 13:22683. [PMID: 38114543 PMCID: PMC10730517 DOI: 10.1038/s41598-023-49377-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2023] [Accepted: 12/07/2023] [Indexed: 12/21/2023] Open
Abstract
The radioscandium isotopes, 43Sc and 47Sc, compose a promising elementally matched theranostic pair that can be used for the development of imaging and therapeutic radiopharmaceuticals with identical structures. This study aimed to investigate the production of high radionuclidic purity 43Sc from enriched [46Ti]TiO2 targets and 47Sc from enriched [50Ti]TiO2 targets and establish a target recycling technique. Enriched [46Ti]TiO2 targets were irradiated with 18 MeV protons, and enriched [50Ti]TiO2 targets were bombarded with 24 MeV protons. 43Sc and 47Sc were purified using ion chromatography attaining recovery yields of 91.7 ± 7.4% and 89.9 ± 3.9%, respectively. The average radionuclidic purity for 43Sc was 98.8 ± 0.3% and for 47Sc 91.5 ± 0.6%, while the average recovery of enriched titanium target material was 96 ± 4.0%. The highest apparent molar activity for [43Sc]Sc-DOTA was 23.2 GBq/µmol and 3.39 GBq/µmol for [47Sc]Sc-DOTA. This work demonstrates the feasibility of using enriched recycled [46Ti]TiO2 and [50Ti]TiO2 targets to produce high purity 43Sc and 47Sc as an elementally matched theranostic isotope pair.
Collapse
Affiliation(s)
- Shelbie J Cingoranelli
- Department of Chemistry, University of Alabama at Birmingham, 1924 6th Ave. S., WTI 310F, Birmingham, AL, 35244, USA
- Department of Radiology, University of Alabama at Birmingham, Birmingham, USA
| | - Jennifer L Bartels
- Department of Radiology, University of Alabama at Birmingham, Birmingham, USA
| | | | - C Shaun Loveless
- Department of Radiology, University of Alabama at Birmingham, Birmingham, USA
| | - David A Rotsch
- Physics Division, Argonne National Laboratory, Lemont, USA
- Radioisotope Science and Technology Division, Oak Ridge National Laboratory, Oak Ridge, USA
| | - Suzanne E Lapi
- Department of Chemistry, University of Alabama at Birmingham, 1924 6th Ave. S., WTI 310F, Birmingham, AL, 35244, USA.
- Department of Radiology, University of Alabama at Birmingham, Birmingham, USA.
| |
Collapse
|
4
|
Phipps MD, Cingoranelli S, Bhupathiraju NVSDK, Younes A, Cao M, Sanders VA, Neary MC, Daveny MH, Cutler CS, Lopez GE, Saini S, Parker CC, Fernandez SR, Lewis JS, Lapi SE, Francesconi LC, Deri MA. Sc-HOPO: A Potential Construct for Use in Radioscandium-Based Radiopharmaceuticals. Inorg Chem 2023; 62:20567-20581. [PMID: 36724083 PMCID: PMC10390652 DOI: 10.1021/acs.inorgchem.2c03931] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Three isotopes of scandium─43Sc, 44Sc, and 47Sc─have attracted increasing attention as potential candidates for use in imaging and therapy, respectively, as well as for possible theranostic use as an elementally matched pair. Here, we present the octadentate chelator 3,4,3-(LI-1,2-HOPO) (or HOPO), an effective chelator for hard cations, as a potential ligand for use in radioscandium constructs with simple radiolabeling under mild conditions. HOPO forms a 1:1 Sc-HOPO complex that was fully characterized, both experimentally and theoretically. [47Sc]Sc-HOPO exhibited good stability in chemical and biological challenges over 7 days. In healthy mice, [43,47Sc]Sc-HOPO cleared the body rapidly with no signs of demetalation. HOPO is a strong candidate for use in radioscandium-based radiopharmaceuticals.
Collapse
Affiliation(s)
- Michael D Phipps
- Ph.D. Program in Chemistry, The Graduate Center of the City University of New York, New York, NY 10016
- Department of Chemistry, City University of New York Hunter College, 695 Park Avenue, New York, New York 10065
- Department of Chemistry, Lehman College of the City University of New York, Bronx, NY 10468
- Medical Isotope Research & Production Laboratory, Collider-Accelerator Division, Brookhaven National Laboratory, Upton, NY, 11973, USA
| | - Shelbie Cingoranelli
- Department of Radiology, University of Alabama at Birmingham, Birmingham, AL 35294
| | | | - Ali Younes
- Department of Chemistry, City University of New York Hunter College, 695 Park Avenue, New York, New York 10065
| | - Minhua Cao
- Department of Chemistry, City University of New York Hunter College, 695 Park Avenue, New York, New York 10065
| | - Vanessa A. Sanders
- Medical Isotope Research & Production Laboratory, Collider-Accelerator Division, Brookhaven National Laboratory, Upton, NY, 11973, USA
| | - Michelle C. Neary
- Department of Chemistry, City University of New York Hunter College, 695 Park Avenue, New York, New York 10065
| | - Matthew H. Daveny
- Department of Chemistry, City University of New York Hunter College, 695 Park Avenue, New York, New York 10065
| | - Cathy S. Cutler
- Medical Isotope Research & Production Laboratory, Collider-Accelerator Division, Brookhaven National Laboratory, Upton, NY, 11973, USA
| | - Gustavo E. Lopez
- Ph.D. Program in Chemistry, The Graduate Center of the City University of New York, New York, NY 10016
- Department of Chemistry, Lehman College of the City University of New York, Bronx, NY 10468
| | - Shefali Saini
- Department of Radiology, University of Alabama at Birmingham, Birmingham, AL 35294
| | - Candace C. Parker
- Department of Radiology, University of Alabama at Birmingham, Birmingham, AL 35294
| | - Solana R. Fernandez
- Department of Radiology, University of Alabama at Birmingham, Birmingham, AL 35294
| | - Jason S. Lewis
- Program in Molecular Pharmacology and Chemistry, Memorial Sloan Kettering Cancer Center, New York, NY 10065
| | - Suzanne E. Lapi
- Department of Radiology, University of Alabama at Birmingham, Birmingham, AL 35294
| | - Lynn C. Francesconi
- Ph.D. Program in Chemistry, The Graduate Center of the City University of New York, New York, NY 10016
- Department of Chemistry, City University of New York Hunter College, 695 Park Avenue, New York, New York 10065
| | - Melissa A. Deri
- Ph.D. Program in Chemistry, The Graduate Center of the City University of New York, New York, NY 10016
- Department of Chemistry, Lehman College of the City University of New York, Bronx, NY 10468
| |
Collapse
|
5
|
Rizk HE, Breky MME, Attallah MF. Development of purification of no-carrier-added 47Sc of theranostic interest: selective separation study from the natTi(n,p) process. RADIOCHIM ACTA 2023. [DOI: 10.1515/ract-2022-0082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
Abstract
Scandium-47 is one of the most promising medical radioisotopes, and its production and trace separation make it an attractive candidate for theranostic application. In this study, the production of no-carrier-added (NCA) 47Sc through the natTi(n,p) reaction and subsequent purification using liquid–liquid extraction was done for the theranostic application. The comparative separation of NCA 47Sc after the dissolution of an activated Ti target using Di-2-Ethylhexyl Phosphoric Acid (HDEHP) in kerosene was evaluated. The extraction process was optimized in terms of the concentration of extractant, extraction time, pH, and reaction temperature to achieve the maximum possible separation. HDEHP is efficient and promising for rapid extraction and separation of NCA 47Sc from Ti ions at low acidity (pH 0.85) with high extraction percent (>99%), contaminated with 22.3% of Ti ions after 5 min of extraction time. Different stripping reagents were used to separate loaded 47Sc and Ti ions. Firstly, 5 M HCl was enough for stripping the loaded Ti ions. Then the loaded 47Sc was separated with a purity of 100% using 0.05 M NaOH. The obtained results find the HDEHP a promising extractant for efficient separation of 47Sc from irradiated Ti target for preparing the 47Sc radiopharmaceuticals for theranostics applications.
Collapse
Affiliation(s)
- Hoda E. Rizk
- Nuclear Fuel Technology Department, Hot Laboratories and Waste Management Center , Egyptian Atomic Energy Authority , Cairo P.O. Box 13759 , Egypt
| | - Mohamed M. E. Breky
- Radiation Protection Department, Hot Laboratories and Waste Management Center , Egyptian Atomic Energy Authority, P.O. Box 13759 , Cairo , Egypt
| | - Mohamed F. Attallah
- Analytical Chemistry and Control Department, Hot Laboratories and Waste Management Center , Egyptian Atomic Energy Authority, P.O. Box 13759 , Cairo , Egypt
| |
Collapse
|
6
|
Attallah MF, Mohamed GY, Breky MME. Production and subsequent separation of 47Sc of nuclear medicine applications using neutron-induced reactions on different natural targets. J Radioanal Nucl Chem 2022. [DOI: 10.1007/s10967-022-08232-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Abstract47Sc can be produced from different three neutron induced nuclear reactions as 47Ti(n,p)47Sc, 50V(n,α)47Sc and 46Ca(n,γ)47Ca, 47Ca(β−)47Sc using the Egyptian Second Research Reactor. The measured neutron cross-sections (σ) are 62.12 ± 1.93, 4.51 ± 1.27 and 69.36 ± 2.01 mb from the natural targets of TiO2, V2O3 and CaO respectively. The carrier-free 47Sc from 47Ti(n,p), was purified using a composite of Alginate–Carboxymethyl cellulose/di-2-ethylhexyl phosphoric acid. The radiochemical separation of 47Sc with a recovery yield of 90 ± 1.2% was obtained. The eluted 47Sc passed quality control tests (chemical, radionuclide, and radiochemical purities) and was found to be suitable for nuclear medicine applications.
Collapse
|
7
|
Mikolajczak R, Huclier-Markai S, Alliot C, Haddad F, Szikra D, Forgacs V, Garnuszek P. Production of scandium radionuclides for theranostic applications: towards standardization of quality requirements. EJNMMI Radiopharm Chem 2021; 6:19. [PMID: 34036449 PMCID: PMC8149571 DOI: 10.1186/s41181-021-00131-2] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2021] [Accepted: 03/26/2021] [Indexed: 01/23/2023] Open
Abstract
In the frame of "precision medicine", the scandium radionuclides have recently received considerable interest, providing personalised adjustment of radiation characteristics to optimize the efficiency of medical care or therapeutic benefit for particular groups of patients. Radionuclides of scandium, namely scandium-43 and scandium-44 (43/44Sc) as positron emitters and scandium-47 (47Sc), beta-radiation emitter, seem to fit ideally into the concept of theranostic pair. This paper aims to review the work on scandium isotopes production, coordination chemistry, radiolabeling, preclinical studies and the very first clinical studies. Finally, standardized procedures for scandium-based radiopharmaceuticals have been proposed as a basis to pave the way for elaboration of the Ph.Eur. monographs for perspective scandium radionuclides.
Collapse
Affiliation(s)
- R Mikolajczak
- Radioisotope Centre POLATOM, National Centre for Nuclear Research, Andrzej Soltan 7, 05-400, Otwock, Poland
| | - S Huclier-Markai
- Laboratoire Subatech, UMR 6457, IMT Nantes Atlantique /CNRS-IN2P3 / Université de Nantes, 4 Rue A. Kastler, BP 20722, 44307, Nantes Cedex 3, France.
- ARRONAX GIP, 1 rue Aronnax, 44817, Nantes Cedex, France.
| | - C Alliot
- ARRONAX GIP, 1 rue Aronnax, 44817, Nantes Cedex, France
- CRCINA, Inserm / CNRS / Université de Nantes, 8 quai Moncousu, 44007, Nantes Cedex 1, France
| | - F Haddad
- Laboratoire Subatech, UMR 6457, IMT Nantes Atlantique /CNRS-IN2P3 / Université de Nantes, 4 Rue A. Kastler, BP 20722, 44307, Nantes Cedex 3, France
- ARRONAX GIP, 1 rue Aronnax, 44817, Nantes Cedex, France
| | - D Szikra
- Faculty of Medicine, Department of Medical Imaging, Division of Nuclear Medicine and Translational Imaging, University of Debrecen, Nagyerdei krt. 98, Debrecen, 4032, Hungary
- Scanomed Ltd., Nagyerdei krt. 98, Debrecen, 4032, Hungary
| | - V Forgacs
- Faculty of Medicine, Department of Medical Imaging, Division of Nuclear Medicine and Translational Imaging, University of Debrecen, Nagyerdei krt. 98, Debrecen, 4032, Hungary
| | - P Garnuszek
- Radioisotope Centre POLATOM, National Centre for Nuclear Research, Andrzej Soltan 7, 05-400, Otwock, Poland
| |
Collapse
|
8
|
Noor A, Van Zuylekom JK, Rudd SE, Roselt PD, Haskali MB, Yan E, Wheatcroft M, Hicks RJ, Cullinane C, Donnelly PS. Imaging Somatostatin Positive Tumors with Tyr 3-Octreotate/Octreotide Conjugated to Desferrioxamine B Squaramide Radiolabeled with either Zirconium-89 or Gallium-68. Bioconjug Chem 2021; 32:1192-1203. [PMID: 33788556 DOI: 10.1021/acs.bioconjchem.1c00109] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Radiolabeled derivatives of Tyr3-octreotide and Tyr3-octreotate, synthetic analogues of the peptide hormone somatostatin, can be used for positron emission tomography (PET) imaging of somatostatin receptor expression in neuroendocrine tumors. In this work, a squaramide ester derivative of desferrioxamine B (H3DFOSq) was used attach either Tyr3-octreotide or Tyr3-octreotate to the metal binding ligand to give H3DFOSq-TIDE and H3DFOSq-TATE. These new peptide-H3DFOSq conjugates form stable complexes with either of the positron-emitting radionuclides gallium-68 (t1/2 = 68 min) or zirconium-89 (t1/2 = 3.3 days). The new complexes were evaluated in an AR42J xenograft model that has endogenous expression of SSTR2. All four agents displayed good tumor uptake and produced high-quality PET images. For both radionuclides, the complexes formed with H3DFOSq-TATE performed better, with higher tumor uptake and retention than the complexes formed with H3DFOSq-TIDE. The versatile ligands presented here can be radiolabeled with either gallium-68 or zirconium-89 at room temperature. The long radioactive half-life of zirconium-89 makes distribution of pre-synthesized tracers produced to certified standards feasible and could increase the number of clinical centers that can perform diagnostic PET imaging of neuroendocrine tumors.
Collapse
Affiliation(s)
- Asif Noor
- School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria 3010, Australia
| | | | - Stacey E Rudd
- School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria 3010, Australia
| | - Peter D Roselt
- Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia
| | - Mohammad B Haskali
- Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia
| | - Eddie Yan
- Telix Pharmaceuticals Limited, Suite 401, 55 Flemington Road, North Melbourne, Victoria 3051, Australia
| | - Michael Wheatcroft
- Telix Pharmaceuticals Limited, Suite 401, 55 Flemington Road, North Melbourne, Victoria 3051, Australia
| | - Rodney J Hicks
- Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.,Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria 3010, Australia
| | - Carleen Cullinane
- Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.,Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria 3010, Australia
| | - Paul S Donnelly
- School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria 3010, Australia
| |
Collapse
|
9
|
Synthesis of chitosan-acrylic acid/multiwalled carbon nanotubes composite for theranostic 47Sc separation from neutron irradiated titanium target. Int J Biol Macromol 2020; 163:79-86. [PMID: 32603728 DOI: 10.1016/j.ijbiomac.2020.06.249] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2020] [Revised: 06/22/2020] [Accepted: 06/25/2020] [Indexed: 11/21/2022]
Abstract
A simple and efficient separation method of carrier-free 47Sc from neutron irradiated titanium target using a novel chitosan-acrylic acid/multiwalled carbon nanotubes (CS-AA/MWCNTs) composite was established. The synthesis of the CS-AA/MWCNTs composite was achieved using gamma radiation-induced template polymerization. The grafting efficiency (GE%) of AA on CS onto the surface of f-MWCNTs reached a maximum of~84% under the optimized conditions (30 wt% CS, 1.0 wt% AA, 0.15 wt% f-MWCNTs, >0.2 wt% N,N'-Methylenebisacrylamide (NMBA), and irradiation dose ~25 kGy). Different analyses (FT-IR, SEM, TGA and DTA) were examined for confirming the structural morphology and mechanical properties of the new synthesized composite. Interestingly, the CS-AA/MWCNTs composite depicted a selective adsorption of Sc(III) rather than Ti(IV) ions at pH 5 with adsorption efficiency of ~93.93%. The ionic exchange separation of no-carrier-added (NCA)47Sc(III) from irradiated TiO2 target on CS-AA/MWCNTs composite packed column efficiently eluted 47Sc(III) by 91 ± 0.8% using 1 M HCl solution. The quality control tests (radionuclidic, radiochemical, and chemical purities) for the eluted 47Sc(III) clarified its high purity and validity for cancer theranostics.
Collapse
|